A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

被引：0

作者：

Park, Byeong-Bae ^{[1
]}

Kim, Won Seog ^{[2
]}

Suh, Cheolwon ^{[3
]}

Yoon, Dok Hyun ^{[3
]}

Won, Jong-Ho ^{[4
]}

Yang, Deok-Hwan ^{[5
]}

Do, Young-Rok ^{[6
]}

Lee, Won Sik ^{[7
]}

Kim, Jeong-A ^{[8
]}

Kim, Min Kyoung ^{[9
]}

Jo, Jae-Cheol ^{[10
]}

Koh, Youngil ^{[11
]}

机构：

[1] Hanyang Univ, Coll Med, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea

[4] Soonchunhyang Univ, Coll Med, Seoul, South Korea

[5] Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea

[6] Dongsan Med Ctr, Daegu, South Korea

[7] Inje Univ, Coll Med, Busan, South Korea

[8] Catholic Univ Korea, St Vincents Hosp, Suwon, South Korea

[9] Yeungnam Univ Med Ctr, Daegu, South Korea

[10] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan, South Korea

[11] Seoul Natl Univ Hosp, Seoul, South Korea

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.1823.1823

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1823

引用

页数：5

共 50 条

[41] High Response Rate of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: Updates of Phase I Trial
Chihara, Dai
Oki, Yasuhiro
Westin, Jason R.
Nastoupil, Loretta
Fayad, Luis E.
Samaniego, Felipe
Wesson, Emily
Ruben, Charnelle
Horowitz, Sandra B.
Feng, Lei
Garg, Naveen
Ahmed, Sairah
Khouri, Issa F.
Hosing, Chitra M.
Romaguera, Jorge E.
Fowler, Nathan
Fanale, Michelle A.
BLOOD, 2015, 126 (23)
[42] Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Coiffier, Bertrand
Federico, Massimo
Caballero, Dolores
Dearden, Claire
Morschhauser, Franck
Jaeger, Ulrich
Truemper, Lorenz
Zucca, Emanuele
da Silva, Maria Gomes
Pettengell, Ruth
Weidmann, Eckhart
d'Amore, Francesco
Tilly, Herve
Zinzani, Pier Luigi
CANCER TREATMENT REVIEWS, 2014, 40 (09) : 1080 - 1088
[43] Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma
Maruyama, Dai
Nagai, Hirokazu
Maeda, Yoshinobu
Nakane, Takahiko
Shimoyama, Tatsu
Nakazato, Tomonori
Sakai, Rika
Ishikawa, Takayuki
Izutsu, Koji
Ueda, Ryuzo
Tobinai, Kensei
CANCER SCIENCE, 2017, 108 (10): : 2061 - 2068
[44] Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
Dhakal, Binod
D'Souza, Anita
Hamadani, Mehdi
Arce-Lara, Carlos
Schroeder, Katrina
Chhabra, Saurabh
Shah, Nirav N.
Gauger, Katelyn
Keaton, Taylor
Pasquini, Marcelo
Hari, Parameswaran
BLOOD CANCER JOURNAL, 2019, 9 (8)
[45] Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Tang, Tiffany
Martin, Peter
Somasundaram, Nagavalli
Lim, Cindy
Tao, Miriam
Poon, Eileen
Yunon, Maica J. D.
Toh, Shu Q.
Yan, Sean X.
Farid, Mohamad
Chan, Jason Y.
Lim, Soon T.
HAEMATOLOGICA, 2021, 106 (12) : 3170 - 3175
[46] Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
Bates, Susan E.
Zhan, Zhirong
Steadman, Kenneth
Obrzut, Tomasz
Luchenko, Victoria
Frye, Robin
Robey, Robert W.
Turner, Maria
Gardner, Erin R.
Figg, William D.
Steinberg, Seth M.
Ling, Alex
Fojo, Tito
To, Kin Wah
Piekarz, Richard L.
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (02) : 256 - 267
[47] Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
Binod Dhakal
Anita D’Souza
Mehdi Hamadani
Carlos Arce-Lara
Katrina Schroeder
Saurabh Chhabra
Nirav N. Shah
Katelyn Gauger
Taylor Keaton
Marcelo Pasquini
Parameswaran Hari
Blood Cancer Journal, 9
[48] Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial
Kumar, Sudhir
Sharma, Atul
Malik, Prabhat Singh
Gogia, Ajay
Pathak, Neha
Sahoo, Ranjit Kumar
Gupta, Ritu
Prasad, Chandra Prakash
Kumar, Lalit
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (02) : 288 - 297
[49] A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
Strati, Paolo
Chihara, Dai
Oki, Yasuhiro
Fayad, Luis E.
Fowler, Nathan
Nastoupil, Loretta
Romaguera, Jorge E.
Samaniego, Felipe
Garg, Naveen
Feng, Lei
Wesson, Emily T.
Ruben, Charnelle E.
Stafford, Mildred D.
Nieto, Yago
Khouri, Issa F.
Hosing, Chitra
Horowitz, Sandra B.
T-Kamble, Rammurti
Fanale, Michelle A.
HAEMATOLOGICA, 2018, 103 (09) : E416 - E418
[50] Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Results of an Interim Analysis
Brammer, Jonathan E.
Zinzani, Pier Luigi
Zain, Jasmine
Mead, Monica
Casulo, Carla
Jacobsen, Eric D.
Gritti, Giuseppe
Litwak, Debra
Cohan, David
Katz, Danica J.
Mehta-Shah, Neha
Pro, Barbara
Horwitz, Steven M.
BLOOD, 2021, 138

← 1 2 3 4 5 →